Natural history of implantable cardioverter-defibrillator implanted at or after the age of 70 years in a veteran population a single center study

Tarek Ajam, Vikas Kalra, Changyu Shen, Xiaochen Li, Sandeep Gautam, Thomas Kambur, Mamta Barmeda, Kyle W. Yancey, Samer Ajam, Jason Garlie, John Miller, Rahul Jain

Research output: Contribution to journalArticle

Abstract

The median age of patients in major Implantable Cardioverter-defibrillator (ICD)trials (MUSTT, MADIT-I, MADIT-II, and SCD-He FT) was 63-67 years; with only 11% ≥70 years. There is little follow-up data on patients over 70 years of age who received an ICD for primary/secondary prevention of sudden cardiac death, particularly for veterans. The aim of this study was to study the natural history of ICD implantation for veterans over 70 years of age. We retrospectively reviewed single center ICD data in 216 patients with a mean age at implantation 76 ± 4 years. The ICD indication was primary prevention in 161 patients and secondary prevention in 55 patients. The ICD indication was unavailable in 4 patients. Mean duration of follow up was 1686 ± 1244 days during which 114 (52%) patients died. Of these, 31% died without receiving any appropriate ICD therapy. Overall, 60/216 (28%) received appropriate therapy and 28/216 (13%) received inappropriate therapy. Patients who had ICD implantation for secondary prophylaxis had statistically more (p= 0.02) appropriate therapies compared to patients who had ICD implantation for primary prevention. Indication for implantation and hypertension predicted appropriate therapy, while age at the time of implantation and presence of atrial fibrillation predicted inappropriate therapies. Overall, 7.7% had device related complications. Although 28% septuagenarians in this study received appropriate ICD therapy, they had high rates of mortality, inappropriate therapy, and device complications. ICD implantation in the elderly merits individualized consideration, with higher benefit for secondary prevention.

Original languageEnglish (US)
JournalJournal of Atrial Fibrillation
Volume9
Issue number4
StatePublished - Dec 1 2016

Fingerprint

Implantable Defibrillators
Veterans
Natural History
Population
Primary Prevention
Secondary Prevention
Therapeutics
Equipment and Supplies
Sudden Cardiac Death
Atrial Fibrillation
Hypertension

Keywords

  • Implantable Cardioverter-Defibrillator
  • Primary prevention
  • Secondary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Natural history of implantable cardioverter-defibrillator implanted at or after the age of 70 years in a veteran population a single center study. / Ajam, Tarek; Kalra, Vikas; Shen, Changyu; Li, Xiaochen; Gautam, Sandeep; Kambur, Thomas; Barmeda, Mamta; Yancey, Kyle W.; Ajam, Samer; Garlie, Jason; Miller, John; Jain, Rahul.

In: Journal of Atrial Fibrillation, Vol. 9, No. 4, 01.12.2016.

Research output: Contribution to journalArticle

Ajam, T, Kalra, V, Shen, C, Li, X, Gautam, S, Kambur, T, Barmeda, M, Yancey, KW, Ajam, S, Garlie, J, Miller, J & Jain, R 2016, 'Natural history of implantable cardioverter-defibrillator implanted at or after the age of 70 years in a veteran population a single center study', Journal of Atrial Fibrillation, vol. 9, no. 4.
Ajam, Tarek ; Kalra, Vikas ; Shen, Changyu ; Li, Xiaochen ; Gautam, Sandeep ; Kambur, Thomas ; Barmeda, Mamta ; Yancey, Kyle W. ; Ajam, Samer ; Garlie, Jason ; Miller, John ; Jain, Rahul. / Natural history of implantable cardioverter-defibrillator implanted at or after the age of 70 years in a veteran population a single center study. In: Journal of Atrial Fibrillation. 2016 ; Vol. 9, No. 4.
@article{8b1852df37c746769f4c5937b86ec99d,
title = "Natural history of implantable cardioverter-defibrillator implanted at or after the age of 70 years in a veteran population a single center study",
abstract = "The median age of patients in major Implantable Cardioverter-defibrillator (ICD)trials (MUSTT, MADIT-I, MADIT-II, and SCD-He FT) was 63-67 years; with only 11{\%} ≥70 years. There is little follow-up data on patients over 70 years of age who received an ICD for primary/secondary prevention of sudden cardiac death, particularly for veterans. The aim of this study was to study the natural history of ICD implantation for veterans over 70 years of age. We retrospectively reviewed single center ICD data in 216 patients with a mean age at implantation 76 ± 4 years. The ICD indication was primary prevention in 161 patients and secondary prevention in 55 patients. The ICD indication was unavailable in 4 patients. Mean duration of follow up was 1686 ± 1244 days during which 114 (52{\%}) patients died. Of these, 31{\%} died without receiving any appropriate ICD therapy. Overall, 60/216 (28{\%}) received appropriate therapy and 28/216 (13{\%}) received inappropriate therapy. Patients who had ICD implantation for secondary prophylaxis had statistically more (p= 0.02) appropriate therapies compared to patients who had ICD implantation for primary prevention. Indication for implantation and hypertension predicted appropriate therapy, while age at the time of implantation and presence of atrial fibrillation predicted inappropriate therapies. Overall, 7.7{\%} had device related complications. Although 28{\%} septuagenarians in this study received appropriate ICD therapy, they had high rates of mortality, inappropriate therapy, and device complications. ICD implantation in the elderly merits individualized consideration, with higher benefit for secondary prevention.",
keywords = "Implantable Cardioverter-Defibrillator, Primary prevention, Secondary prevention",
author = "Tarek Ajam and Vikas Kalra and Changyu Shen and Xiaochen Li and Sandeep Gautam and Thomas Kambur and Mamta Barmeda and Yancey, {Kyle W.} and Samer Ajam and Jason Garlie and John Miller and Rahul Jain",
year = "2016",
month = "12",
day = "1",
language = "English (US)",
volume = "9",
journal = "Journal of Atrial Fibrillation",
issn = "1941-6911",
publisher = "Cardiofront, Inc.",
number = "4",

}

TY - JOUR

T1 - Natural history of implantable cardioverter-defibrillator implanted at or after the age of 70 years in a veteran population a single center study

AU - Ajam, Tarek

AU - Kalra, Vikas

AU - Shen, Changyu

AU - Li, Xiaochen

AU - Gautam, Sandeep

AU - Kambur, Thomas

AU - Barmeda, Mamta

AU - Yancey, Kyle W.

AU - Ajam, Samer

AU - Garlie, Jason

AU - Miller, John

AU - Jain, Rahul

PY - 2016/12/1

Y1 - 2016/12/1

N2 - The median age of patients in major Implantable Cardioverter-defibrillator (ICD)trials (MUSTT, MADIT-I, MADIT-II, and SCD-He FT) was 63-67 years; with only 11% ≥70 years. There is little follow-up data on patients over 70 years of age who received an ICD for primary/secondary prevention of sudden cardiac death, particularly for veterans. The aim of this study was to study the natural history of ICD implantation for veterans over 70 years of age. We retrospectively reviewed single center ICD data in 216 patients with a mean age at implantation 76 ± 4 years. The ICD indication was primary prevention in 161 patients and secondary prevention in 55 patients. The ICD indication was unavailable in 4 patients. Mean duration of follow up was 1686 ± 1244 days during which 114 (52%) patients died. Of these, 31% died without receiving any appropriate ICD therapy. Overall, 60/216 (28%) received appropriate therapy and 28/216 (13%) received inappropriate therapy. Patients who had ICD implantation for secondary prophylaxis had statistically more (p= 0.02) appropriate therapies compared to patients who had ICD implantation for primary prevention. Indication for implantation and hypertension predicted appropriate therapy, while age at the time of implantation and presence of atrial fibrillation predicted inappropriate therapies. Overall, 7.7% had device related complications. Although 28% septuagenarians in this study received appropriate ICD therapy, they had high rates of mortality, inappropriate therapy, and device complications. ICD implantation in the elderly merits individualized consideration, with higher benefit for secondary prevention.

AB - The median age of patients in major Implantable Cardioverter-defibrillator (ICD)trials (MUSTT, MADIT-I, MADIT-II, and SCD-He FT) was 63-67 years; with only 11% ≥70 years. There is little follow-up data on patients over 70 years of age who received an ICD for primary/secondary prevention of sudden cardiac death, particularly for veterans. The aim of this study was to study the natural history of ICD implantation for veterans over 70 years of age. We retrospectively reviewed single center ICD data in 216 patients with a mean age at implantation 76 ± 4 years. The ICD indication was primary prevention in 161 patients and secondary prevention in 55 patients. The ICD indication was unavailable in 4 patients. Mean duration of follow up was 1686 ± 1244 days during which 114 (52%) patients died. Of these, 31% died without receiving any appropriate ICD therapy. Overall, 60/216 (28%) received appropriate therapy and 28/216 (13%) received inappropriate therapy. Patients who had ICD implantation for secondary prophylaxis had statistically more (p= 0.02) appropriate therapies compared to patients who had ICD implantation for primary prevention. Indication for implantation and hypertension predicted appropriate therapy, while age at the time of implantation and presence of atrial fibrillation predicted inappropriate therapies. Overall, 7.7% had device related complications. Although 28% septuagenarians in this study received appropriate ICD therapy, they had high rates of mortality, inappropriate therapy, and device complications. ICD implantation in the elderly merits individualized consideration, with higher benefit for secondary prevention.

KW - Implantable Cardioverter-Defibrillator

KW - Primary prevention

KW - Secondary prevention

UR - http://www.scopus.com/inward/record.url?scp=85017544266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017544266&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85017544266

VL - 9

JO - Journal of Atrial Fibrillation

JF - Journal of Atrial Fibrillation

SN - 1941-6911

IS - 4

ER -